[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
July 1982

Neuropharmacology of Central Nervous System and Behavioral Disorders

Arch Neurol. 1982;39(7):459. doi:10.1001/archneur.1982.00510190077037

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


The editorial intent was to bring basic research in neuropsychopharmacology together with its clinical application in psychiatry and neurology. Many eminent authorities contributed chapters. A compendium of wellwritten, timely, but disjointed papers has resulted.

The book has roughly two parts. The first describes current pharmacologic treatment of selected psychiatric and neurologic disorders. The second is devoted to diverse special topics with an emphasis on basic research.

Clinical psychiatric topics include theories of affective disorders, childhood behavior disorders, anxiety, and insomnia. The subjects reviewed include the following: pharmacologic management of affective disorders; basic features of tricyclics; and the pharmacology of monoamine oxidase inhibitors, lithium compounds, neuroleptics, benzodiazepines, β-adrenergic blockers, and hypnotics.

The more clinically oriented chapters on psychiatry range in quality from satisfactory to weak. The chapters on affective disorders, anxiety disorders, and insomnia are adequate. The chapter on β-adrenergic blockers is quite good, although occasionally it has the flavor of

First Page Preview View Large
First page PDF preview
First page PDF preview